Adverse events that occurred more frequently with LY@ than with placebo included injection site pain , erythema , or both ( @ -LSB- @ % -RSB- of @ vs seven -LSB- @ % -RSB- of @ ) , upper respiratory tract infections ( @ -LSB- @ % -RSB- vs ten -LSB- @ % -RSB- ) , and abdominal pain ( six -LSB- @ % -RSB- vs three -LSB- @ % -RSB- ) .